IsolariciresinolCAS# 548-29-8 |
- (-)-Isolariciresinol
Catalog No.:BCX0425
CAS No.:110268-37-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 548-29-8 | SDF | Download SDF |
PubChem ID | 160521 | Appearance | Powder |
Formula | C20H24O6 | M.Wt | 360.4 |
Type of Compound | Lignans | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (6R,7R,8S)-8-(4-hydroxy-3-methoxyphenyl)-6,7-bis(hydroxymethyl)-3-methoxy-5,6,7,8-tetrahydronaphthalen-2-ol | ||
SMILES | COC1=C(C=C2C(C(C(CC2=C1)CO)CO)C3=CC(=C(C=C3)O)OC)O | ||
Standard InChIKey | OGFXBIXJCWAUCH-KPHUOKFYSA-N | ||
Standard InChI | InChI=1S/C20H24O6/c1-25-18-6-11(3-4-16(18)23)20-14-8-17(24)19(26-2)7-12(14)5-13(9-21)15(20)10-22/h3-4,6-8,13,15,20-24H,5,9-10H2,1-2H3/t13-,15-,20-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Isolariciresinol has antioxidant and anti-inflammatory activities during an in vitro gastro-intestinal digestion of the Radix Isatidis extract (RIE). |
Targets | Immunology & Inflammation related |
Isolariciresinol Dilution Calculator
Isolariciresinol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.7747 mL | 13.8735 mL | 27.7469 mL | 55.4939 mL | 69.3674 mL |
5 mM | 0.5549 mL | 2.7747 mL | 5.5494 mL | 11.0988 mL | 13.8735 mL |
10 mM | 0.2775 mL | 1.3873 mL | 2.7747 mL | 5.5494 mL | 6.9367 mL |
50 mM | 0.0555 mL | 0.2775 mL | 0.5549 mL | 1.1099 mL | 1.3873 mL |
100 mM | 0.0277 mL | 0.1387 mL | 0.2775 mL | 0.5549 mL | 0.6937 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Isoginkgetin
Catalog No.:BCN2320
CAS No.:548-19-6
- Roemerine
Catalog No.:BCN8236
CAS No.:548-08-3
- Hypericin
Catalog No.:BCN5977
CAS No.:548-04-9
- BMS-345541
Catalog No.:BCC1423
CAS No.:547757-23-3
- JTE 013
Catalog No.:BCC7348
CAS No.:547756-93-4
- Fluvoxamine
Catalog No.:BCC4214
CAS No.:54739-18-3
- 4-(4-Hydroxyphenyl)-2-butanone
Catalog No.:BCN6797
CAS No.:5471-51-2
- 20-Deoxyingenol
Catalog No.:BCN3770
CAS No.:54706-99-9
- Dodecanoic acid ingenol ester
Catalog No.:BCN8291
CAS No.:54706-70-6
- 8-Hydroxy-7-iodo-5-quinolinesulfonic acid
Catalog No.:BCC8788
CAS No.:547-91-1
- 4'-Benzyloxyacetophenone
Catalog No.:BCC8698
CAS No.:54696-05-8
- 2-(Acetylamino)-3-phenyl-2-propenoic acid
Catalog No.:BCN1420
CAS No.:5469-45-4
- Oxysanguinarine
Catalog No.:BCN8100
CAS No.:548-30-1
- Cornin
Catalog No.:BCN5008
CAS No.:548-37-8
- Crystal Violet
Catalog No.:BCC4772
CAS No.:548-62-9
- Quercetagetin-7-O-glucoside
Catalog No.:BCN6480
CAS No.:548-75-4
- Irigenin
Catalog No.:BCN3849
CAS No.:548-76-5
- Tectorigenin
Catalog No.:BCN1019
CAS No.:548-77-6
- Pinobanksin
Catalog No.:BCN5729
CAS No.:548-82-3
- Galangin
Catalog No.:BCN5730
CAS No.:548-83-4
- Gyrophoric acid
Catalog No.:BCN5731
CAS No.:548-89-0
- Trichodesmine
Catalog No.:BCN2145
CAS No.:548-90-3
- Protoveratrine B
Catalog No.:BCN2435
CAS No.:124-97-0
- Daphneolone
Catalog No.:BCN3230
CAS No.:54835-64-2
In vitro antioxidant and anti-inflammatory activities of Radix Isatidis extract and bioaccessibility of six bioactive compounds after simulated gastro-intestinal digestion.[Pubmed:25256688]
J Ethnopharmacol. 2014 Nov 18;157:55-61.
ETHNOPHARMACOLOGICAL RELEVANCE: Radix Isatidis called "Ban-Lan-Gen" is one of the most commonly-used traditional Chinese medicines for antiviral, anti-inflammatory, antioxidant and antipyretic purposes. Investigate the bioaccessibility of uridine, epigoitrin, adenosine, clemastanin B, indigoticoside A and Isolariciresinol as well as the antioxidant and anti-inflammatory activities during an in vitro gastro-intestinal digestion of the Radix Isatidis extract (RIE). MATERIALS AND METHODS: High performance liquid chromatography (HPLC) technique was adopted to determine the bioaccessibility of six bioactive compounds in RIE. Antioxidant activities of RIE in different digestive stages were determined by 1,1-Diphenyl-2-picrylhydrazyl (DPPH), superoxide anion and hydroxyl radical scavenging abilities. Anti-inflammatory activity was assayed by the inhibitions of inflammatory cytokines such as nitrous oxide (NO), prostaglandin E2 (PGE2) and tumor necrosis factor alpha(TNF-alpha) producted by lipopolysaccharide (LPS) stimulated RAW264.7 cells. RESULTS: The bioaccessibility of uridine, epigoitrin, adenosine, clemastanin B, indigoticoside A and Isolariciresinol were 15.38%, 18.28%, 24.01%, 6.50%, 8.65% and 17.78%, respectively. Also, the digestion products still possessed certain antioxidant activities. The antioxidant activity was highly correlated with lignans (clemastanin B, indigoticoside A and isolariciresino). The anti-inflammation activity of the three samples decreased in the order: IN sample (the solution that had diffused into the dialysis tubing)>Nondigested sample (RIE solution)>Gastric sample (post-gastric digestion)>OUT sample (material that remained in the gastro-intestinal tract). CONCLUSIONS: Results obtained in this research reveal the amount of bioactive compounds from RIE that could be available for absorption in vivo. The antioxidant activity decreased significantly but the anti-inflammatory activity was enhanced in serum-available fraction after gastro-intestinal digestion in vitro. This study could provide a scientific basis for a deeper pharmacological activity study of Radix Isatidis and a simple method for pharmacodynamic material basis research.